Shortening the treatment of tuberculosis

MeSH terms

• Animals
• Antitubercular Agents / chemistry
• Antitubercular Agents / pharmacokinetics
• Antitubercular Agents / pharmacology*
• Antitubercular Agents / therapeutic use
• Bacterial Proton-Translocating ATPases / antagonists & inhibitors*
• Bacterial Proton-Translocating ATPases / chemistry
• Bacterial Proton-Translocating ATPases / metabolism
• Dose-Response Relationship, Drug
• Drug Evaluation, Preclinical
• Drug Resistance, Bacterial
• Drug Therapy, Combination
• Enzyme Inhibitors / chemistry
• Enzyme Inhibitors / pharmacology
• Enzyme Inhibitors / therapeutic use
• Humans
• Male
• Mice
• Microbial Sensitivity Tests
• Molecular Sequence Data
• Mycobacterium smegmatis / drug effects
• Mycobacterium smegmatis / enzymology
• Mycobacterium smegmatis / growth & development
• Mycobacterium tuberculosis / drug effects*
• Mycobacterium tuberculosis / enzymology
• Mycobacterium tuberculosis / growth & development
• Point Mutation
• Protein Subunits / antagonists & inhibitors
• Protein Subunits / chemistry
• Quinolines / chemistry
• Quinolines / pharmacokinetics
• Quinolines / pharmacology*
• Quinolines / therapeutic use*
• Tuberculosis / drug therapy*
• Tuberculosis / microbiology
• Tuberculosis, Multidrug-Resistant / drug therapy
• Tuberculosis, Multidrug-Resistant / microbiology